CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
8.16
-0.18 (-2.16%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close8.34
Open8.27
Bid7.00 x 200
Ask9.25 x 100
Day's Range8.10 - 8.62
52 Week Range5.42 - 10.80
Volume204,172
Avg. Volume131,933
Market Cap397.936M
Beta1.87
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 3 Biotech Stocks That Soared This Week: Are They Buys?
    Motley Fool13 days ago

    3 Biotech Stocks That Soared This Week: Are They Buys?

    Sorrento Therapeutics, ChemoCentryx, and Insys started off 2018 great. But can their momentum continue?

  • Here's Why ChemoCentryx Rose as Much as 53.5% Today
    Motley Fool15 days ago

    Here's Why ChemoCentryx Rose as Much as 53.5% Today

    The tiny biopharma stock is cruising on today's news. Does it deserve the pop?

  • Capital Cube22 days ago

    ETFs with exposure to ChemoCentryx, Inc. : December 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ChemoCentryx, Inc. Here are 5 ETFs with the largest exposure to CCXI-US. Comparing the performance and risk of ChemoCentryx, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
    Capital Cube23 days ago

    ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017

    Categories: Yahoo FinanceGet free summary analysis ChemoCentryx, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ChemoCentryx, Inc. – Fortress Biotech, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR and Pfizer Inc. (FBIO-US, TEVA-US and PFE-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)

  • Should You Buy ChemoCentryx Inc (CCXI) Now?
    Simply Wall St.2 months ago

    Should You Buy ChemoCentryx Inc (CCXI) Now?

    ChemoCentryx Inc (NASDAQ:CCXI), a biotechnology company based in United States, saw significant share price volatility over the past couple of months on the NasdaqGS, rising to the highs of $8.42Read More...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CCXI earnings conference call or presentation 7-Nov-17 10:00pm GMT

    Q3 2017 ChemoCentryx Inc Earnings Call

  • Capital Cube2 months ago

    ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : November 10, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ChemoCentryx, Inc. a score of 21. Our analysis is based on comparing ChemoCentryx, Inc. with the following peers – Fortress Biotech, Inc., Biogen Inc., Johnson & Johnson, AbbVie, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Pfizer Inc. and ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to ChemoCentryx, Inc. : November 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ChemoCentryx, Inc. Here are 5 ETFs with the largest exposure to CCXI-US. Comparing the performance and risk of ChemoCentryx, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : November 9, 2017
    Capital Cube2 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : November 9, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : October 20, 2017
    Capital Cube3 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : October 20, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to ChemoCentryx, Inc. : October 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ChemoCentryx, Inc. Here are 5 ETFs with the largest exposure to CCXI-US. Comparing the performance and risk of ChemoCentryx, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
    Capital Cube4 months ago

    ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017

    Categories: Yahoo FinanceGet free summary analysis ChemoCentryx, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 8.94 million, Net Earnings of USD -9.24 million. Change in operating cash flow of -121.02% compared to same period last year is about the same as change in earnings, likely no significant movement ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : October 3, 2017
    Capital Cube4 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : October 3, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • All You Need To Know About ChemoCentryx Inc’s (CCXI) Risks
    Simply Wall St.4 months ago

    All You Need To Know About ChemoCentryx Inc’s (CCXI) Risks

    If you are looking to invest in ChemoCentryx Inc’s (NASDAQ:CCXI), or currently own the stock, then you need to understand its beta in order to understand how it can affectRead More...

  • Is There Now An Opportunity In ChemoCentryx Inc (CCXI)?
    Simply Wall St.4 months ago

    Is There Now An Opportunity In ChemoCentryx Inc (CCXI)?

    ChemoCentryx Inc (NASDAQ:CCXI), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a decent share price growth in the teens level on the NasdaqGS over the lastRead More...

  • Capital Cube5 months ago

    ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : August 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ChemoCentryx, Inc. a score of 21. Our analysis is based on comparing ChemoCentryx, Inc. with the following peers – Fortress Biotech, Inc., Biogen Inc., Johnson & Johnson, AbbVie, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Pfizer Inc. and ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of CCXI earnings conference call or presentation 8-Aug-17 9:00pm GMT

    Q2 2017 ChemoCentryx Inc Earnings Call

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : August 10, 2017
    Capital Cube5 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : August 10, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Associated Press5 months ago

    ChemoCentryx reports 2Q loss

    The Mountain View, California-based company said it had a loss of 19 cents per share. The biopharmaceutical company posted revenue of $8.9 million in the period. ChemoCentryx shares have climbed 37 percent ...

  • New Strong Buy Stocks for July 18th
    Zacks6 months ago

    New Strong Buy Stocks for July 18th

    New Strong Buy Stocks for July 18th

  • ChemoCentryx (CCXI) Catches Eye: Stock Moves Up 6.4%
    Zacks6 months ago

    ChemoCentryx (CCXI) Catches Eye: Stock Moves Up 6.4%

    ChemoCentryx, Inc. (CCXI) moved big last session, as its shares rose over 6% on the day.

  • Capital Cube7 months ago

    ETFs with exposure to ChemoCentryx, Inc. : June 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ChemoCentryx, Inc. Here are 5 ETFs with the largest exposure to CCXI-US. Comparing the performance and risk of ChemoCentryx, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : June 8, 2017
    Capital Cube7 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : June 8, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of CCXI earnings conference call or presentation 10-May-17 9:00pm GMT

    Q1 2017 ChemoCentryx Inc Earnings Call

  • Capital Cube8 months ago

    ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : May 15, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ChemoCentryx, Inc. a score of 21. Our analysis is based on comparing ChemoCentryx, Inc. with the following peers – Fortress Biotech, Inc., Biogen Inc., Johnson & Johnson, AbbVie, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Pfizer Inc. and ... Read more (Read more...)